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A 28-year-old male with B-cell acute lymphoblastic leukemia presented to our pulmonary clinic with
progressive dyspnea, cough, hemoptysis, and fever. Diagnostic bronchoscopy revealed white masses at
the entrance of the right middle lobe bronchus and distal to the right main bronchus. Histopathological
examination of the biopsy specimen showed those masses to be hyphae of Aspergillus.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Aspergillus spp. can cause a variety of pulmonary diseases,
depending on the immune status of the individual and the presence
of underlying lung disease. Pulmonary aspergilloma, allergic
bronchopulmonary aspergillosis, chronic necrotizing pulmonary
aspergillosis, and invasive aspergillosis are the most common
clinical presentations of pulmonary infections due to Aspergillus
species [1e4]. Endobronchial aspergilloma is an unusual presen-
tation of pulmonary aspergillosis [5] and is characterized by the
growth of Aspergillus species into the bronchial lumen. Endobron-
chial aspergilloma can mimic endobronchial tumors in terms of the
clinical and radiographic presentation. Here, the study describes a
case of endobronchial aspergilloma in a patient with B-cell acute
lymphoblastic leukemia.2. Case report
A 28-year-old male previously diagnosed with relapsed B-cell
acute lymphoblastic leukemia presented to our pulmonary clinic
with progressive dyspnea, cough, hemoptysis and fever. Ausculta-
tion revealed bilateral rhonchi. On admission, the complete blood
count results were normal: white blood cells, 5,000/mm3 (41.7%ases, Yuzuncu Yil University
oglu).
Ltd. This is an open access article uneutrophils, 49.0% lymphocytes, and 0.1% eosinophils); hemoglo-
bin, 8.5 g/dL; and platelets, 18,000/mm3 after chemotherapy. The C-
reactive protein level was 57 mg/IU. Bilateral multiple opacities
were detected on the chest X-ray (Fig. 1). Computed tomography
revealed multiple areas of consolidation distributed randomly
throughout the lung (Fig. 2). Bronchoscopy was performed for
evaluate the cause of hemoptysis and to diagnose lung paren-
chymal lesions. Diagnostic ﬂexible bronchoscopy revealed that,
distal to the right main bronchus, the right lung middle lobe
bronchial entrances were narrowed by a white mass (Fig. 3). A bi-
opsy was obtained from the white mass at the entrance of the
middle lobe bronchus. Microscopy of the biopsy samples showed
fungal hyphae that stained with Peryodik Asit Shift(PAS) (Fig. 4),
and Aspergillus fumigatus was grown in culture. The patient was
diagnosed as aspergillosis and voriconazole was started.
3. Discussion
Endobronchial aspergilloma is a rare presentation of pulmonary
aspergillosis. It can present as a noninvasive form of aspergillosis
characterized by growth of Aspergillus spp. within the bronchi, with
or without parenchymal lesions or cavities. Aspergillus airway
infection can complicate the course of various malignant diseases,
the risk being highest in severely immunocompromised patients
with hematological malignancies.
The clinical presentation of aspergillosis is quite diverse. Many
patients are asymptomatic, although some present with symptoms
such as cough, dyspnea, hypoxia, hemoptysis and weight loss. Thender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Chest radiogram demonstrating multiple opacities. Fig. 2. Thorax computed tomogram showing consolidated areas in the lung distributed
randomly.
Fig. 4. The histologic examination shows numerous hyphae with background necrotic debris hematoxylin and eosin. 400(A), Peryodik Asit Shift(PAS) (B).
Fig. 3. The bronchoscopy shows a whitish mass lesion causing partially obstruction of distal the right main bronchus (A), and complete obstruction of entrance the middle lobe
bronchus (B).
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respiratory failure has previously been reported [6,7]. In addition,
the need for mechanical ventilation drastically affects mortality
rates, which have been reported to be 94% for endobronchial
aspergillosis patients on mechanical ventilation, compared with
25% for those not requiring mechanical ventilation [8].
In many cases, endobronchial aspergilloma is incidentally
detected in patients who have undergone bronchoscopy to evaluate
the cause of hemoptysis and to diagnose parenchymal lung lesions
[5]. Bronchoscopic ﬁndings vary from yellowish-white necrotic
plaques to whitish nodules.
Since the most reliable criterion of fungal airway disease is
demonstration of tissue invasion and damage caused by hyphae
[9e11], bronchoscopy with biopsy, microscopy, and culture is the
only way to conﬁrm invasive Aspergillus tracheobronchial infection
in the clinical setting [12].
The optimal treatment or duration of therapy for endobronchial
aspergilloma has yet to be established since this unique pre-
sentation of Aspergillus seen in immunocompetent indivi-duals
are usually diagnosed incidentally. Treatment options include
amphotericin B, voriconazole, itraconazole, and caspofungin.
Finally, although endobronchial aspergilloma is extremely rare,
it should be considered in the differential diagnosis of endobron-
chial masses in immunocompromised patients.
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